The increasing number of surgical procedures worldwide is significantly boosting the growth of the global tissue adhesives market. According to the United Nations, 2023, as the global population grows and ages—1 in 6 people are now aged 65 or older, a figure
projected to rise to 1 in 4 by 2050 demand for both elective and emergency surgeries continue to surge. According to the Wantstats
secondary analysis, over 360 million major surgical procedures were performed globally in 2023, driven by aging demographics and
chronic disease prevalence. Moreover, 2024 Annals of Surgery meta-analysis highlighted that tissue adhesives are increasingly
preferred by surgeons for wound closure due to their advantages over traditional sutures, including 30–50% faster application times
and a 35% reduction in surgical site infections. Additionally, patients treated with tissue adhesives experience 20–25% shorter
recovery periods, which is critical for improving post-operative outcomes. The global tissue adhesives market is projected to grow at a significant rate, fuelled by adoption in specialties such as dermatology,
orthopedics, and cardiovascular surgery.
For instance, American Society for Dermatologic Surgery, Dermatologists who are
members of the American Society for Dermatologic Surgery (ASDS carried out almost 14 million medically essential and cosmetic
procedures in 2019, marking an 11% increase from 2018 and a 78% rise since 2012 with tissue adhesives preferred for minimizing
scarring in cosmetic surgeries. According to the European Commission, in 2022, a total of 1.06 million transluminal coronary
angioplasty procedures were performed across the 25 EU countries with available data. This represents an increase of more than
3,500 procedures compared to 2017. As per the, Journal of Minimally Invasive Surgery, 2024, with 85% of surgeries expected to
adopt minimally invasive techniques by 2030, tissue adhesives are pivotal in reducing complications such as postoperative leakage
by 40% and enhancing patient satisfaction. This trend underscores their essential role in advancing surgical precision, efficiency,
and recovery outcomes worldwide. Technological advancements in tissue adhesive products have significantly contributed to the growth of the global tissue adhesives
market. Innovations such as bio-inspired adhesives, nanotechnology, and improved polymer chemistry have led to the development
of more efficient, biocompatible, and stronger adhesives.
For instance, a 2023 study in Nature Biomedical Engineering highlighted
that advanced polymer-based adhesives reduce wound closure time by 25% compared to traditional methods, while
nanotechnology-enhanced formulations improve tensile strength by over 30%. These advancements enable tissue adhesives to
bond better with human tissue, promote faster wound healing, and reduce the risk of infection, which is critical given that surgical
site infections (SSIs) affect up to 5% of postoperative patients globally reported by WHO, 2023. Moreover, the introduction of new delivery systems, such as spray and gel forms, has accelerated adoption. According to the Journal
of Clinical Medicine, 2023, the growing preference for minimally invasive procedures—expected to account for 72% of all surgeries
by 2025—has further boosted demand, as tissue adhesives offer a suture-free alternative that minimizes scarring and recovery time. As these technologies evolve, they promise not only enhanced patient outcomes but also increased adoption across diverse
healthcare settings. This trajectory positions the global tissue adhesives market for sustained growth, aligning with broader shifts
toward efficient, patient-centric care. The aging population across the globe is a key driver of the growth in the global tissue adhesive market.
As per America’s Health
Rankings, approximately 58 million adults ages 65 and older were living in the US in 2022, and this number was projected to grow
nearly 22% in the US in 2040. According to the European Commission, there were 448.8 million people, and more than one fifth of
them were aged 65 years and over in Europe. As per the Asia-Pacific Report on Population Ageing 2022, there were approximately
670 million people aged 60 or older in Asia-Pacific in 2022. Also, it has been estimated that the number will double to approximately
1.3 billion people by 2050 in Asia-Pacific. According to the United Nations, 2023, age-related health conditions such as chronic
wounds, surgical procedures, and skin injuries are more susceptible. Moreover, the National Institute on Aging, 2023, chronic
wounds alone affect 2.5% of the elderly population annually, driving demand for efficient wound management solutions like tissue
adhesives. Tissue adhesives, offering a quicker, less painful, and minimally invasive alternative to traditional sutures and staples, are
increasingly preferred for treating older adults. Journal of the American Geriatrics Society, 2024 studies indicate that tissue
adhesives reduce procedure time by 30–50% compared to sutures, critical for elderly patients with comorbidities.
Furthermore,
Wound Repair and Regeneration, 2023, reported that advanced adhesives improve healing outcomes in older adults, whose wound
healing capacity is 40% slower than younger individuals, by reducing infection risks and accelerating recovery. Additionally, OECD Health Statistics, 2023, stated that the rising demand for safer, easier-to-apply treatments is evident, with 62%
of surgeons in geriatric care now prioritizing adhesives for superficial wounds and post-surgical closures. This trend aligns with
the broader shift toward outpatient care, where tissue adhesive use in elderly patients has surged. As the aging demographic
expands, healthcare systems wor
